Laser fabrication of composite layers from biopolymers with branched 3D networks of single-walled carbon nanotubes for cardiovascular implants
|
15.03.2021 |
Gerasimenko A.Y.
Kurilova U.E.
Savelyev M.S.
Murashko D.T.
Glukhova O.E.
|
Composite Structures |
10.1016/j.compstruct.2020.113517 |
0 |
Ссылка
© 2020 Elsevier Ltd A laser technology has been developed for fabricating structures from composite layers based on biopolymers: albumin, collagen, and chitosan with single-walled carbon nanotubes (SWCNT). The structures are intended for cardiovascular devices and tissue-engineered implants. This is evidenced by the results of studies. The composite layers were fabricated due to the phase transition of biopolymers and SWCNT aqueous dispersion under the influence of laser pulses. At the same time branched 3D networks of SWCNT were formed in the biopolymer matrix. The threshold energy fluence of laser pulses was determined (0.032–0.083 J/cm2) at which a bimodal distribution of pores was observed. The calculation of contact resistances between nanotubes at percolation units of 3D networks (20–100 kOhm) was carried out. Composite layers fabricated by laser demonstrated conductivity values that were higher (12.4 S/m) than those for layers by thermostat (4.7 S/m). The maximum hardness of the composite layers with SWCNT (0.01 wt%) by laser was 482 ± 10, 425 ± 10, and 407 ± 15 MPa for albumin, collagen and chitosan, respectively. The hardness of the thermostat layers was less than 100 MPa. The viability of endothelial cells in composite layers was improved. The composite layers ensured a normal level of hemolysis during interaction with erythrocytes.
Читать
тезис
|
Effects of Novel Potential Analgesic Compounds on the Cardiovascular and Respiratory Systems
|
01.10.2018 |
Palikova Y.
Skobtsova L.
Palikov V.
Belous G.
Khokhlova O.
Lobanov A.
Slashcheva G.
Rzhevskii D.
Rudenko V.
Kalabina E.
Osipova G.
Andreev Y.
Logashina Y.
Kozlov S.
Yavorskii A.
Elyakova G.
D’yachenko I.
|
Pharmaceutical Chemistry Journal |
|
0 |
Ссылка
© 2018, Springer Science+Business Media, LLC, part of Springer Nature. The polypeptide analgesic compounds APCH3 (a TRPV1 receptor inhibitor) and PT1 (a P 2 X 3 receptor inhibitor) were shown not to act on the cardiovascular system or respiratory system when given either as single or multiple doses in mice. The low molecular weight compound sevanol (an ASIC3 receptor inhibitor) had no effect on the cardiovascular system, but prolonged use for 14 days affected measures of the respiratory system, significantly increasing respiratory rate and peak expiratory flow rate.
Читать
тезис
|
Hybrid mock circulatory loop for training and study purposes
|
13.06.2018 |
Telyshev D.
Pugovkin A.
Selishchev S.
Ruschen D.
Leonhardt S.
|
Proceedings - 2018 Ural Symposium on Biomedical Engineering, Radioelectronics and Information Technology, USBEREIT 2018 |
|
1 |
Ссылка
© 2018 IEEE. A hybrid mock circulatory loop (MCL) intended for training and study of engineers and physicians involved into ventricular assist devices design and development is described in this paper. Represented hybrid MCL allow to simulate different cardiovascular conditions including normal and heart failure states.
Читать
тезис
|
Effects of fixed combination of indacaterol/glycopyrronium in chronic obstructive pulmonary disease: State-of-the art review
|
01.01.2018 |
Avdeev S.
Trushenko N.
|
Pulmonologiya |
|
1 |
Ссылка
© 2018 Medical Education. All rights reserved. Long-acting bronchodilators (long-acting β 2 -agonists (LABA), long-acting anticholinergics (LAMA) and their combinations) are the basic drugs for treatment of stable chronic obstructive pulmonary disease (COPD). Indacaterol/glycopyrronium (IND/GLY) is the first fixed LABA/LAMA combination acquired significant evidence of its efficacy for improvement lung function, symptoms, and quality of life, and decrease in the rate of acute exacerbations of COPD. The aim of this review was to reassess clinical efficacy of IND/GLY in treatment of COPD with regard to recent data and to outline the further role of this combination in therapy of COPD.
Читать
тезис
|
Homocysteine and homocysteine-related compounds: An overview of the roles in the pathology of the cardiovascular and nervous systems
|
01.01.2018 |
Djuric D.
Jakovljevic V.
Zivkovic V.
Srejovic I.
|
Canadian Journal of Physiology and Pharmacology |
|
1 |
Ссылка
© 2018, Canadian Science Publishing. All rights reserved. Homocysteine, an amino acid containing a sulfhydryl group, is an intermediate product during metabolism of the amino acids methionine and cysteine. Hyperhomocysteinemia is used as a predictive risk factor for cardiovascular disorders, the stroke progression, screening for inborn errors of methionine metabolism, and as a supplementary test for vitamin B12 deficiency. Two organic systems in which homocysteine has the most harmful effects are the cardiovascular and nervous system. The adverse effects of homocysteine are achieved by the action of several different mechanisms, such as overactivation of N-methyl-D-aspartate receptors, activation of Toll-like receptor 4, disturbance in Ca2+ handling, increased activity of nicotinamide adenine dinucleotide phosphate-oxidase and subsequent increase of production of reactive oxygen species, increased activity of nitric oxide synthase and nitric oxide synthase uncoupling and consequent impairment in nitric oxide and reactive oxygen species synthesis. Increased production of reactive species during hyperhomocysteinemia is related with increased expression of several proinflammatory cytokines, including IL-1α, IL-6, TNF-α, MCP-1, and intracellular adhesion molecule-1. All these mechanisms contribute to the emergence of diseases like atherosclerosis and related complications such as myocardial infarction, stroke, aortic aneurysm, as well as Alzheimer disease and epilepsy. This review provides evidence that supports the causal role for hyperhomocysteinemia in the development of cardiovascular disease and nervous system disorders.
Читать
тезис
|